Physician profile
Grayson H Wheatley
NPI 1083615934
$899,598.58
in general payments reported to CMS, 2019-2025
8 companies · $188K in 2025
The $188K reported for 2025 was more than what 99% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $137K · 2020: $75K · 2021: $37K · 2022: $78K · 2023: $147K · 2024: $239K · 2025: $188K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $493K · Travel and Lodging: $72K · Food and Beverage: $9,261.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $492,567.34 |
| Travel and Lodging | $72,182.86 |
| Food and Beverage | $9,260.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medical Device Business Services, INC. | $692,138.80 | 2019-2025 | Vistaseal, Surgicel Nu-Knit, Surgiflo Hemostatic Matrix |
| Ethicon US, LLC | $181,899.35 | 2019-2025 | Vistaseal, Ethicon, Surgicel Nu-Knit |
| Medtronic Vascular, INC. | $16,104.59 | 2019 | |
| Ethicon INC. | $6,630.00 | 2019-2021 | |
| Bolton Medical INC | $1,508.90 | 2019 | |
| Synthes USA Products LLC | $916.44 | 2022 | |
| Biom'Up Sa | $350.75 | 2019 | |
| Abiomed | $49.75 | 2023 | Impella |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Grayson Wheatley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.